Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

Revenue of YES! discounters increased by 19.8%

1/31/24 OKEY

Polymetal summarized its performance in 2023

1/31/24 POLY

Qiwi sold Russian assets

1/31/24 QIWI

TCS Group has withdrawn from the capital of cryptocurrency service Aximetria

1/30/24 T

SPB Exchange withdrew from the capital of ITS

1/30/24 SPBE

Mechel sold the port of Kambarka in Udmurtia

1/30/24 MTLR

SPB Exchange issued the first digital rights

1/30/24 SPBE

UGC obtained a license for a new area near Vysokoye mine

1/30/24 UGLD

SPB Exchange denied that trading in Russian securities had been halted

1/30/24 SPBE

SPB Exchange completely stops conducting trading

1/30/24 SPBE